Dübendorf ZH - The Empa spin-off Siloxene is seeking to make a multifunctional material component available on the market. With this, the properties of adhesives, coatings or fillers can be improved in targeted fashion.

Matthias Koebel has been CEO of the newly founded Empa start-up Siloxene AG since the beginning of 2021. Image: Empa
Matthias Koebel has been CEO of the newly founded Empa start-up Siloxene AG since the beginning of 2021. Image: Empa

Following a successful research career at the Swiss Federal Laboratories for Materials Science and Technology (Empa), Matthias Koebel founded his own start-up by the name of Siloxene. With his company, Koebel has set his sights on commercializing a multifunctional material component that he discovered and researched during his time at Empa.

In a press release, Empa described this development as a sort of “miracle material” for the chemicals industry. In specific terms, this component is a silicon-based, molecular hybrid building material that measures only around a single nanometer in size. Using this material, the properties of adhesives, coatings or fillers can be enhanced depending on the product and in line with customer requirements. For example, coatings can be made more scratch-resistant, while shorter curing times are possible for adhesives. Empa draws a comparison between this material and the Crispr/Cas genetic scissors, which can be used to cure genetic diseases and which were awarded a Nobel Prize for Medicine.

With his new start-up based in Dübendorf in the canton of Zurich, Koebel is primarily seeking to target companies operating in the plastics processing, adhesives or sealants manufacturing, and construction materials industries. “Here, the regulatory hurdles are not as high and we can work with companies to optimize their products and processes relatively easily”, he explains in the press release.

At the moment, Koebel is focused on expanding his research and development department in addition to gaining further customers. His vision initially includes plans for a contract manufacturer to handle production of the macromolecule. “In the long term, however, I would like to set up our own production”, he underlines.

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line. 

+41 44 254 59 59


info@greaterzuricharea.com